|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
NZ336840A
(en)
*
|
1997-02-03 |
2001-01-26 |
Pfizer Prod Inc |
Arylsulfonylamino hydroxamic acid derivatives useful in the treatment of tumor necrosis factor and matrix metalloproteinase mediated diseases
|
|
CA2298617A1
(en)
|
1997-07-31 |
1999-02-11 |
Yetunde Olabisi Taiwo |
Acyclic metalloprotease inhibitors
|
|
WO2000037433A1
(en)
*
|
1998-12-18 |
2000-06-29 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6946473B2
(en)
*
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
US6358980B1
(en)
|
1999-01-27 |
2002-03-19 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
BR0008716A
(pt)
|
1999-03-03 |
2002-09-24 |
Procter & Gamble |
Inibidores de metaloprotease contendo alquenil ou alquinil
|
|
MXPA01008857A
(es)
|
1999-03-03 |
2002-07-02 |
Procter & Gamble |
Inhibidores de metaloproteasa dihetero sustituidos.
|
|
SE0100902D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
SE0100903D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
BR0213736A
(pt)
*
|
2001-11-01 |
2004-10-19 |
Wyeth Corp |
ácidos hidroxâmicos de sulfonamida de arila alênica como metaloproteinase matriz e inibidores de tace
|
|
SE0103710D0
(sv)
*
|
2001-11-07 |
2001-11-07 |
Astrazeneca Ab |
Compounds
|
|
KR100701811B1
(ko)
|
2002-05-29 |
2007-04-02 |
머크 앤드 캄파니 인코포레이티드 |
탄저병의 치료 및 치사 인자의 억제에 유용한 화합물
|
|
SE0202539D0
(sv)
*
|
2002-08-27 |
2002-08-27 |
Astrazeneca Ab |
Compounds
|
|
GB0221246D0
(en)
*
|
2002-09-13 |
2002-10-23 |
Astrazeneca Ab |
Compounds
|
|
US7199155B2
(en)
*
|
2002-12-23 |
2007-04-03 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
|
|
AU2003300076C1
(en)
|
2002-12-30 |
2010-03-04 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
|
BRPI0407587A
(pt)
*
|
2003-02-18 |
2006-02-14 |
Pfizer |
inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
|
|
JP4790594B2
(ja)
*
|
2003-02-25 |
2011-10-12 |
トポターゲット ユーケー リミテッド |
Ｈｄａｃインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
|
|
AU2005250351A1
(en)
|
2004-05-11 |
2005-12-15 |
Merck & Co., Inc. |
Process for making n-sulfonated-amino acid derivatives
|
|
SE0401762D0
(sv)
*
|
2004-07-05 |
2004-07-05 |
Astrazeneca Ab |
Novel compounds
|
|
US7648992B2
(en)
|
2004-07-05 |
2010-01-19 |
Astrazeneca Ab |
Hydantoin derivatives for the treatment of obstructive airway diseases
|
|
ITFI20040174A1
(it)
*
|
2004-08-03 |
2004-11-03 |
Protera S R L |
Derivati arilsolfonammidici dell'acido idrossammico ad azione inibitoria di metalloproteinasi
|
|
US20100003276A1
(en)
*
|
2004-12-07 |
2010-01-07 |
Hermes Jeffery D |
Methods for treating anthrax and inhibiting lethal factor
|
|
SE0403086D0
(sv)
*
|
2004-12-17 |
2004-12-17 |
Astrazeneca Ab |
Compounds
|
|
SE0403085D0
(sv)
*
|
2004-12-17 |
2004-12-17 |
Astrazeneca Ab |
Novel componds
|
|
TW200831488A
(en)
*
|
2006-11-29 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
|
CA3082972C
(en)
|
2017-11-27 |
2022-10-11 |
Council Of Scientific & Industrial Research |
Indole (sulfomyl) n-hydroxy benzamide derivatives as selective hdac inhibitors
|
|
WO2026015506A1
(en)
*
|
2024-07-11 |
2026-01-15 |
Purdue Research Foundation |
Dual inhibitors for hdac3 and hiv-1 pr
|